HIGHLIGHTS
- who: Report from the (UNIVERSITY) have published the research: Review began 11/14/2022 Review ended 11/20/2022 Published 11/25/2022 u00a9 Copyright, in the Journal: (JOURNAL) of November/25,/2022
- what: HCL is a disease that requires a combination of diagnostic options including morphology, histopathology, flow cytometry, and clinical findings to make an accurate diagnosis.
- how: MRD results showed that the percentage of hair cells decreased to less than 1%. The authors chose the combination regimen of rituximab and fludarabine when abnormal immunophenotypic markers were detected and good treatment results . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.